Anna Tarján1, Mária Dudás2, Lucas Wiessing3, Gergely Horváth4, Erzsébet Rusvai5, Bálint Tresó5, Ágnes Csohán2. 1. Hungarian Reitox National Focal Point, Albert Flórián út 2-6, Budapest 1097, Hungary; Semmelweis University, School of PhD Studies, Üllői u. 26, Budapest 1085, Hungary. Electronic address: tarjan.anna@gmail.com. 2. Department for Communicable Diseases, National Centre for Epidemiology, Albert Flórián út 2-6, Budapest 1097, Hungary. 3. European Monitoring Centre for Drugs and Drug Addiction, Praça Europa 1, Cais do Sodré, Lisbon 1249-289, Portugal. 4. Hungarian Reitox National Focal Point, Albert Flórián út 2-6, Budapest 1097, Hungary; Semmelweis University, School of PhD Studies, Üllői u. 26, Budapest 1085, Hungary. 5. Division of Virology, National Centre for Epidemiology, Albert Flórián út 2-6, Budapest 1097, Hungary.
Abstract
BACKGROUND: In Hungary a large increase in injecting new psychoactive substances (NPS) coincided with decreasing harm reduction efforts and rising HCV infection. We describe these, and assess changes in HCV prevalence and risk behaviours, 2011-2014, among NPS injectors, using 2011-2015 syringe exchange programme (SEP) data as a key contextual ('risk environment') variable. METHODS: We conducted repeated national sero-behavioural surveys in people who inject drugs (PWID) injecting in the last month and attending SEPs or drug treatment centres (n=399, 2011; 384, 2014), using face-to-face interviews and dried blood-spot samples. Prevalence of injected drugs and SEP coverage (2011-2015) were assessed through our national SEP monitoring system and using population size estimates. RESULTS: NPS injecting tripled among PWID attending SEPs in Hungary (2011: 26%; 2015: 80%). Among NPS injectors, HCV prevalence, sharing syringes and sharing any injecting equipment (last month), doubled (2011-2014: 37%-74%, 20%-48%, 42%-71%, respectively), significantly exceeding prevalence in other PWID groups. Among young NPS injectors (aged<25), HCV prevalence increased 7-fold (12%-76%), among new injectors (injecting<2years) 4-fold (13%-42%), coupled with high levels of equipment sharing (79% and 72% respectively). Not using a condom at last intercourse (79%), ever-imprisonment (65%) and last-year homelessness (57%) were highly prevalent among NPS injectors (2014). The number of syringes distributed per estimated PWID nationally fell from 114 to 81 (2011-2014) and dropped to 28 in 2015. CONCLUSION: NPS injectors in Hungary are at severe risk of blood-borne infections due to high levels of injecting and sexual risk behaviours within a high-risk environment, including continuously low SEP provision, imprisonment and homelessness. An HIV outbreak cannot be excluded. Stronger investment in evidence-based prevention measures, with special focus on young and new injectors, and expansion of hepatitis C treatment are urgently needed.
BACKGROUND: In Hungary a large increase in injecting new psychoactive substances (NPS) coincided with decreasing harm reduction efforts and rising HCV infection. We describe these, and assess changes in HCV prevalence and risk behaviours, 2011-2014, among NPS injectors, using 2011-2015 syringe exchange programme (SEP) data as a key contextual ('risk environment') variable. METHODS: We conducted repeated national sero-behavioural surveys in people who inject drugs (PWID) injecting in the last month and attending SEPs or drug treatment centres (n=399, 2011; 384, 2014), using face-to-face interviews and dried blood-spot samples. Prevalence of injected drugs and SEP coverage (2011-2015) were assessed through our national SEP monitoring system and using population size estimates. RESULTS: NPS injecting tripled among PWID attending SEPs in Hungary (2011: 26%; 2015: 80%). Among NPS injectors, HCV prevalence, sharing syringes and sharing any injecting equipment (last month), doubled (2011-2014: 37%-74%, 20%-48%, 42%-71%, respectively), significantly exceeding prevalence in other PWID groups. Among young NPS injectors (aged<25), HCV prevalence increased 7-fold (12%-76%), among new injectors (injecting<2years) 4-fold (13%-42%), coupled with high levels of equipment sharing (79% and 72% respectively). Not using a condom at last intercourse (79%), ever-imprisonment (65%) and last-year homelessness (57%) were highly prevalent among NPS injectors (2014). The number of syringes distributed per estimated PWID nationally fell from 114 to 81 (2011-2014) and dropped to 28 in 2015. CONCLUSION: NPS injectors in Hungary are at severe risk of blood-borne infections due to high levels of injecting and sexual risk behaviours within a high-risk environment, including continuously low SEP provision, imprisonment and homelessness. An HIV outbreak cannot be excluded. Stronger investment in evidence-based prevention measures, with special focus on young and new injectors, and expansion of hepatitis C treatment are urgently needed.
Authors: Hannah Fraser; Jon Zibbell; Thomas Hoerger; Susan Hariri; Claudia Vellozzi; Natasha K Martin; Alex H Kral; Matthew Hickman; John W Ward; Peter Vickerman Journal: Addiction Date: 2017-09-20 Impact factor: 6.526
Authors: Sarah Larney; Amy Peacock; Janni Leung; Samantha Colledge; Matthew Hickman; Peter Vickerman; Jason Grebely; Kostyantyn V Dumchev; Paul Griffiths; Lindsey Hines; Evan B Cunningham; Richard P Mattick; Michael Lynskey; John Marsden; John Strang; Louisa Degenhardt Journal: Lancet Glob Health Date: 2017-10-23 Impact factor: 26.763
Authors: Deborah Dal Farra; Alice Valdesalici; Giancarlo Zecchinato; Alfio De Sandre; Diego Saccon; Pierluigi Simonato; Ornella Corazza; Giovanni Martinotti; Andrew L Smith; Marco Solmi Journal: Int J Environ Res Public Health Date: 2022-01-14 Impact factor: 3.390